Archiv článků

Benefits and Negatives of Corticosteroid Therapy in Corneal Patients Journal > /cs/journal/2017/2/6
Introduction: Corticosteroid therapy is very beneficial in many types of eye diseases. Corticosteroids are used in the treatment of inflammatory and immunological diseases of the eye. Purpose: The aim is to present basic informations about effects of steroids in tissues, their side effects and treatment strategy. Methods and results: Authors process overview of local and systemic steroids and thei...
The Current Possibilities of Ophthalmological Diagnosis and Co-operation between Ophthalmologists and Neurologists for Patients with Idiopathic Intracranial Hypertension Journal > /cs/journal/2016/2/5
Purpose: The aim of this paper is to present the current possibilities in idiopatic intracranial hypertension (IIH) diagnostics. Optical coherence tomography belongs to these possibilities in last few years. The necesarry interdisciplinary co-operation of ophthalmologist and neurologist concerning in IIH patients is pointed out in the mentioned case reports. Material and methods: The issue of diag...
Effect of Ranibizumab and Aflibercept on Retinal Pigment Epithelial Detachment, Subretinal, and Intra-Retinal Fluid in Age-Related Macular Degeneration Journal > /cs/journal/2022/4/3
Purpose: The aim of the study was to compare the effect of three initial doses of the anti-VEGF ranibizumab and aflibercept medication on serous pigment epithelial detachment (PED), subretinal fluid (SRF) and intraretinal fluid (IRF) in the macula of treatment naive neovascular AMD (nvAMD) patients. Material and Methods: The cohort consists of 148 patients, of which 74 patients were treated with r...
Pars Plana Vitrectomy in the Treatment of Rhegmatogenous Retinal Detachment Journal > /cs/journal/2024/1/2
Aim: The aim of the study is to retrospectively evaluate the anatomical success rate and functional results of 25G+ PPV in the treatment of newly diagnosed rhegmatogenous retinal detachment (RRD). Material and Methods: The set consists of 152 eyes of 152 patients, of which 71 (47%) were men, average age 54 years, operated on by one surgeon for RRD at the Eye Clinic of the University Hospital and M...
Surgical Treatment of Rhegmatogenous Retinal Detachment in the Only Seeing Eye Journal > /cs/journal/2025/1/4
Aim: To retrospectively evaluate the anatomical and functional success of surgical treatment of rhegmatogenous retinal detachment (RRD) in the only remaining seeing eye. Material and methods: The study included 28 eyes of 28 patients, 19 (68%) of whom were men, with an average age of 46 years. They were operated on by a single surgeon for RRD at the Eye Clinic of the University Hospital and Facult...
Rhegmatogenous Retinal Detachment in Childhood Journal > /cs/journal/2025/5/2
Aims: To retrospectively evaluate the anatomical and functional success of surgical treatment for rhegmatogenous retinal detachment (RRD) in pediatric patients aged 18 years and younger. Material and methods: The study includes 14 eyes of 14 patients, 9 (64%) of whom were males, with an average age of 12 years. All patients underwent surgery for rhegmatogenous retinal detachment (RRD) performed by...
Choroidal Neovascular Membrane in Pediatric Patients: Long-Term Outcomes of Anti-VEGF Therapy Journal > /cs/journal/2026/2/2
Aim: To evaluate the epidemiological data, etiology and clinical characteristics, and to assess the efficacy and safety of intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy in the treatment of choroidal neovascular membrane (CNV) in children and adolescents. The results are compared with data from previously published studies and case reports. Material and Methods: Retrospec...
Central Serous Chorioretinopathy as a Masquerading Syndrome of Choroidal Hemangioma Journal > /cs/journal/2016/6/3
Introduction: The finding of the neuroretinal ablation in fovea centralis area on Optic Coherence Tomography (OCT) examination in young men is a typical finding for central serous choroidoretinopathy. This finding may masquerade the presence of the choroidal hemangioma. Case report: The author presents case reports of two young men, in which, according to the finding of neuroretinal ablation on OC...
The Use of Anti-VEGF Preparations and PDT in the Treatment of Retinal Juxtapapillary Hemangioma – A Case Report Journal > /cs/journal/2014/5/5
Aim: The aim of this paper is to present clinical experience with the therapy of retinal juxtapapillary hemangioma using the intravitreal application of anti-VEGF substance (bevacizumab) and photodynamic therapy (PDT) with verteporfine (Visudyne). Material and methods: The authors present a case of a 34 years old male patient with diagnosed retinal hemangioma localized on the optic disc. Subjectiv...
Contraception and Ocular Thromboembolic Episodes Journal > /cs/journal/2013/2/7
The aim of the paper is to warn of the retinal vein occlusion possibility due to the using of hormonal contraceptive pills in young female patients. A case report of 22 years old female patient hospitalized at the Department of Ophthalmology, School of Medicine, Masaryk University, Brno, Czech Republic, E.U., with sudden decrease of the left eye visual acuity is presented. After excluding other ca...
Photodynamic Therapy with Verteporfin in Treatment of Wet Form ARMD – Long Term Results Journal > /cs/journal/2012/3/1
Photodynamic therapy with Verteporfin (Visudyne - Novartis AG, Basel, Switzerland) is a method designed for treatment of the wet form of age-related macular degeneration. Effectiveness of photodynamic therapy with Verteporfin we approved on our department in group of 301 patients (114 males, 187 women) of average age 73.5 years with predominantly classic choroidal neovascular membrane in subfoveal...
Photodynamic Therapy with Verteporfin in Treatment of Myopic Neovascular Choroideal Membranes Journal > /cs/journal/2012/4/1
The aim of this study was to evaluate efficiency and long-term stabilization effect in patients with classic type of myopic choroidal neovascular membrane (CNV), treated with photodynamic therapy (PDT) with verteporfin (Visudyne – Novartis AG, Basel, Switzerland). We have verified the efficiency of photodynamic therapy with verteporfin in group of 51 eyes (17 men, 34 women), mean age 49,5 years wi...
Ranibizumab in the ARMD Wet Form Treatment – Two Years Results Obtained from the AMADEuS Registry Journal > /cs/journal/2012/5/1
Aim: The aim of this study was the retrospective follow up of Age-Related Macular Degeneration (ARMD) wet form patients treated with ranibizumab during 24 months period. The data were recorded into the AMADEuS (Age-related MAcular DEgeneration in patientS in the Czech Republic) Registry and after their evaluation compared with treatment results obtained from other departments of ophthalmology coll...